Alwin Capital
Overview
Alwin Capital is a venture capital firm in China specializing in early-stage life science investments . Driven by theme-focused research in life science, Alwin Capital has developed investment strategies that capture outstanding opportunities for innovative diagnostic and therapeutic developments . The firm is committed to long-term investment in life science with the pursuit of excess investment return based on scientific insights . Alwin Capital has formed a systematic investment layout covering Innovative Drugs, Molecular Diagnostics, Innovative Hardware, Scientific Services and AI Applications .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Abogen Biosciences | Aug 2021 | Series C | - |
| Edge Medical Robotics | Jan 2021 | Series B | Co-investor |
| Keya Medical | Nov 2020 | Series C | Co-investor |
| Beijing Rosenbot Technology Co., Ltd. | Feb 2021 | Series A | Co-investor |
| BioLink | Nov 2024 | Strategic | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Alwin Capital based?
Alwin Capital is headquartered in Beijing, Beijing, China.
When was Alwin Capital founded?
Alwin Capital was founded in 2015.
How many portfolio companies does Alwin Capital have?
Alwin Capital has 23 portfolio companies in Caplight's dataset.
What are some companies in Alwin Capital's portfolio?
Portfolio companies visible on Caplight include Abogen Biosciences, Edge Medical Robotics, Keya Medical, Beijing Rosenbot Technology Co., Ltd., BioLink.
What was Alwin Capital's most recent investment shown here?
Alwin Capital's most recent investment in this portfolio sample was in BioLink in 2024.
What sectors does Alwin Capital focus on?
Alwin Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Mobility, Transportation & Logistics, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Alwin Capital focus on?
Alwin Capital typically invests at the MultiStage stage.
What is Alwin Capital's AUM?
Alwin Capital's assets under management are estimated between $500.0M and $1.0B.